Sciberras, D G <br/><br/>
Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist.  [electronic resource] 

 -  British journal of clinical pharmacology  Jan 1997 
 - 49-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0306-5251 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2125.1997.tb00032.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Analysis of Variance<br/>Blood Pressure--drug effects<br/>Double-Blind Method<br/>Heart Rate--drug effects<br/>Humans<br/>Male<br/>Migraine Disorders--metabolism<br/>Serotonin Receptor Agonists--adverse effects<br/>Sumatriptan--pharmacokinetics<br/>Triazoles--adverse effects<br/>Tryptamines